We are proud to announce that MesenFlow has been awarded funding from the Swiss Innovation Agency, Innosuisse, to support the development of our next-generation vascularized organoid platform.

This project is being carried out in collaboration with HEPIA Geneva School of Engineering, Architecture and Landscape, combining expertise in tissue engineering and micro-physiological systems to advance translational organoid modeling.

The grant will support the development of innovative organoid-integrated vascular flow systems designed to better replicate complex human tissue environments under physiological conditions.

This initiative represents an important milestone in expanding MesenFlow’s platform toward advanced tissue modeling and translational applications in drug development.

We thank Innosuisse and our academic partners at HEPIA for their support and collaboration in driving this innovation forward.

‍

‍

‍